Maternal Immune Activation and Neurodevelopmental Disorders: Integrating Molecular, Cellular and Systems Mechanisms
Neuropsychiatric Disease and Treatment · 2025-11 · Volume 21 · 2575-2594
DOI: 10.2147/ndt.s533813 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropsychiatric Disease and Treatment, 2025-11. Verfasst von Qi Yong und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Seventh Affiliated Hospital Hengyang Medical School, University of South China (Hunan Provincial Veterans Administration Hospital), Changsha, Hun…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Neurodevelopmental Disorders (NDDs) represent chronic cerebral dysfunctions arising from gene-environment interactions, encompassing conditions such Autism Spectrum Disorders (ASD) and attention-deficit/hyperactivity disorders (ADHD). Emerging evidence identifies Maternal immune activation (MIA) as a critical environmental risk factor for NDDs. Gestational infections, inflammatory responses, or immune dysregulation elevate maternal-fetal inflammatory mediators, which disrupt neurodevelopmental trajectories via placental-fetal signaling cascades. Preclinical models (rodents, non-human primates) demonstrate that MIA induces characteristic NDD phenotypes-including social deficits and cognitive impairments-through microglial hyperactivation, aberrant synaptic pruning, oxidative stress, and mitochondrial dysfunction. Concurrently, gut microbiota dysbiosis and Th17/Treg immune imbalance exacerbate neuroinflammatory processes. Novel therapeutic strategies targeting inflammatory pathways microglial modulation, or microbial homeostasis restoration show translational promise. Future investigations must unravel MIA's molecular underpinnings and multifactorial interactions to enable early-risk stratification and precision interventions for NDDs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Seventh Affiliated Hospital Hengyang Medical School, University of South China (Hunan Provincial Veterans Administration Hospital), Changsha, Hunan, 410000, People's Republic of China.
- Hunan Key Laboratory of Medical Genetics, MOE Key Laboratory of Pediatric Rare Diseases, School of Life Sciences, Central South University, Changsha, Hunan, 410083, People's Republic of China.
- MOE Key Laboratory of Pediatric Rare Diseases, University of South China, Hengyang, Hunan, 421001, People's Republic of China.
- Department of Critical Care Medicine, Shenzhen Third People's Hospital, Shenzhen, Guangdong, 518112, People's Republic of China.
ORCID-Profile: Qi Yong
Zitieren
APA
Yong, Q., Zhao, C., Xia, L., Zhu, T., & Xia, K. (2025). Maternal Immune Activation and Neurodevelopmental Disorders: Integrating Molecular, Cellular and Systems Mechanisms. Neuropsychiatric Disease and Treatment, Volume 21, 2575-2594. https://doi.org/10.2147/ndt.s533813
Vancouver
Yong Q, Zhao C, Xia L, Zhu T, Xia K. Maternal Immune Activation and Neurodevelopmental Disorders: Integrating Molecular, Cellular and Systems Mechanisms. Neuropsychiatric Disease and Treatment. 2025;Volume 21:2575-2594. doi:10.2147/ndt.s533813
BibTeX
@article{Yong2025,
author = {Yong, Qi and Zhao, Chao and Xia, Lu and Zhu, Tengfei and Xia, Kun},
title = {Maternal Immune Activation and Neurodevelopmental Disorders: Integrating Molecular, Cellular and Systems Mechanisms},
journal = {Neuropsychiatric Disease and Treatment},
year = {2025},
volume = {Volume 21},
pages = {2575--2594},
doi = {10.2147/ndt.s533813}
}
EUVIMED